We are live on ! Find out more
PCP

Pacific Capital Partners Portfolio holdings

AUM $116M
1-Year Est. Return 24.59%
This Fund
S&P 500
This Quarter Est. Return
+11.92%
1 Year Est. Return
+24.59%
3 Year Est. Return
+49.79%
5 Year Est. Return
10 Year Est. Return
AUM
$153M
AUM Growth
+$20.2M
Cap. Flow
+$5.03M
Cap. Flow %
3.29%
Top 10 Hldgs %
47.78%
Holding
60
New
4
Increased
17
Reduced
12
Closed
2

Top Buys

Rank Stock Value
1
AER icon
AerCap
AER
+$3.93M
2
FTRE icon
Fortrea Holdings
FTRE
+$1.73M
3
CNMD icon
CONMED
CNMD
+$1.31M
4
FIS icon
Fidelity National Information Services
FIS
+$1.3M
5
VSTS icon
Vestis
VSTS
+$990K

Top Sells

Rank Stock Value
1
RSG icon
Republic Services
RSG
+$1.33M
2
TRU icon
TransUnion
TRU
+$1.1M
3
CRH icon
CRH
CRH
+$764K
4
FTV icon
Fortive
FTV
+$736K
5
CVSA
Covista Inc
CVSA
+$701K

Sector Composition

Rank Sector Weight
1 Healthcare 46.69%
2 Industrials 27.2%
3 Financials 10.73%
4 Materials 6.02%
5 Consumer Discretionary 4.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BKNG icon
26
Booking.com
BKNG
$159B
$1.69M 1.11%
11,675
HOLX
27
DELISTED
Hologic
HOLX
$1.69M 1.1%
21,660
+2,539
+13% +$189K
ABBV icon
28
AbbVie
ABBV
$470B
$1.64M 1.08%
9,026
+727
+9% +$125K
CG icon
29
Carlyle Group
CG
$17.2B
$1.63M 1.07%
34,800
UNH icon
30
UnitedHealth
UNH
$349B
$1.52M 1%
3,080
TECK icon
31
Teck Resources
TECK
$31.8B
$1.49M 0.97%
32,500
MRK icon
32
Merck
MRK
$370B
$1.49M 0.97%
11,270
+2,239
+25% +$276K
FIS icon
33
Fidelity National Information Services
FIS
$20.9B
$1.48M 0.97%
+20,000
New +$1.3M
BC icon
34
Brunswick
BC
$5.16B
$1.48M 0.97%
15,343
TMO icon
35
Thermo Fisher Scientific
TMO
$229B
$1.37M 0.9%
2,358
+323
+16% +$181K
BSX icon
36
Boston Scientific
BSX
$73.5B
$1.25M 0.82%
18,244
AXNX
37
DELISTED
Axonics, Inc. Common Stock
AXNX
$1.16M 0.76%
16,872
-7,508
-31% -$507K
EXAS
38
DELISTED
Exact Sciences
EXAS
$1.15M 0.75%
16,638
+3,657
+28% +$231K
COO icon
39
Cooper Companies
COO
$14.9B
$1.12M 0.73%
11,056
STRA icon
40
Strategic Education
STRA
$1.84B
$1.1M 0.72%
10,551
+1,328
+14% +$130K
PRCT icon
41
Procept Biorobotics
PRCT
$1.25B
$1.07M 0.7%
21,699
+3,700
+21% +$176K
TMDX icon
42
Transmedics
TMDX
$3.22B
$1.06M 0.7%
14,373
+1,820
+14% +$150K
HUM icon
43
Humana
HUM
$46.2B
$974K 0.64%
2,810
LLY icon
44
Eli Lilly
LLY
$1.12T
$969K 0.63%
1,246
VSTS icon
45
Vestis
VSTS
$1.68B
$964K 0.63%
+50,000
New +$990K
AMP icon
46
Ameriprise Financial
AMP
$49.4B
$876K 0.57%
1,998
COLM icon
47
Columbia Sportswear
COLM
$3.06B
$854K 0.56%
10,523
HCA icon
48
HCA Healthcare
HCA
$88.2B
$832K 0.54%
2,495
ECL icon
49
Ecolab
ECL
$79.6B
$812K 0.53%
3,515
CVS icon
50
CVS Health
CVS
$120B
$755K 0.49%
9,471

Similar funds

Pacific Capital Partners's Q1 2024 Portfolio in Review

As of Q1 2024, Pacific Capital Partners held 60 positions worth $153M, up 15% from $133M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Pacific Capital Partners deployed $5.03M of net new capital in Q1 2024, opening 4 new positions and adding to 17 existing holdings. Its largest new stake was AerCap: 50,000 shares worth $4.35M.

By sector, the portfolio is most concentrated in Healthcare at 47% of assets, down from 48% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was Republic Services, an estimated $1.33M trimmed.

  • Pacific Capital Partners's largest Q1 2024 buy was AerCap: 50,000 shares worth $4.35M.
  • Pacific Capital Partners added most to CONMED in Q1 2024, an estimated $1.31M increase.
  • Pacific Capital Partners's biggest Q1 2024 reduction was Republic Services, cutting an estimated $1.33M.
  • Pacific Capital Partners fully exited Fortive in Q1 2024, selling an estimated $736K.
  • Pacific Capital Partners's ten largest holdings make up 48% of its $153M portfolio in Q1 2024.
  • Pacific Capital Partners opened 4 new positions and closed 2 in Q1 2024.
  • Pacific Capital Partners's portfolio value rose 15% quarter-over-quarter to $153M.

Based on Pacific Capital Partners's 13F filing for Q1 2024, filed 8 May 2025.